APLT - Applied Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 85.04M
Enterprise Value 63.43M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)6.04
Price/Book (mrq)4.89
Enterprise Value/Revenue 5.95
Enterprise Value/EBITDA -0.90

Trading Information

Stock Price History

Beta (5Y Monthly) 1.89
52-Week Change 315.75%
S&P500 52-Week Change 314.65%
52 Week High 32.1800
52 Week Low 30.5000
50-Day Moving Average 31.2864
200-Day Moving Average 31.0407

Share Statistics

Avg Vol (3 month) 3409.16k
Avg Vol (10 day) 3225.15k
Shares Outstanding 557.85M
Implied Shares Outstanding 6N/A
Float 830.67M
% Held by Insiders 112.07%
% Held by Institutions 166.19%
Shares Short (May 14, 2023) 4594.41k
Short Ratio (May 14, 2023) 40.68
Short % of Float (May 14, 2023) 41.31%
Short % of Shares Outstanding (May 14, 2023) 41.03%
Shares Short (prior month Apr 13, 2023) 4350.23k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 0.00%
Operating Margin (ttm)-663.29%

Management Effectiveness

Return on Assets (ttm)-93.08%
Return on Equity (ttm)-366.97%

Income Statement

Revenue (ttm)10.66M
Revenue Per Share (ttm)0.23
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-69.52M
Diluted EPS (ttm)-1.4900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)22.92M
Total Cash Per Share (mrq)0.4
Total Debt (mrq)774k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.87
Book Value Per Share (mrq)-0.09

Cash Flow Statement

Operating Cash Flow (ttm)-60.67M
Levered Free Cash Flow (ttm)-21.83M